Analyzing infections caused by 11 respiratory pathogens in children: Pre- and post-COVID-19 pandemic trends in China

Huamei Li1, Ying Yang2, Ran Tao1

  • 1Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, China.

Journal of Medical Virology
|September 23, 2024
PubMed

Insights

Following COVID-19 restrictions, pediatric respiratory pathogen detection rates significantly increased in 2023 compared to 2022. Key pathogens like influenza and Mycoplasma pneumoniae surged, alongside shifts in epidemic seasons and susceptible age groups.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Respiratory virology and bacteriology

Background:

  • The lifting of COVID-19 restrictions in China in December 2022 led to widespread infections.
  • Understanding the impact on other respiratory pathogens in children is crucial for public health.
  • Changes in pathogen circulation patterns post-pandemic require investigation.

Purpose of the Study:

  • To analyze the epidemiological shifts of pediatric respiratory pathogens before and after the COVID-19 pandemic.
  • To compare pathogen detection rates and identify changes in seasonality and susceptible populations.
  • To inform future public health strategies for managing pediatric respiratory infections.

Main Methods:

  • Retrospective analysis of 44,704 children with acute respiratory infections.
  • Multiplex polymerase chain reaction (PCR) testing for 11 respiratory pathogens.
  • Comparison of data from February-December 2022 versus February-December 2023.

Main Results:

  • Overall pathogen detection rate (74.80% vs. 56.01%) and coinfection rates (12.21% vs. 5.89%) were significantly higher in 2023.
  • Increased detection of Influenza A, Influenza B, human parainfluenza virus, human metapneumovirus, respiratory syncytial virus, and Mycoplasma pneumoniae in 2023.
  • Decreased detection of human adenovirus and human bocavirus; stable rates for Chlamydia, human rhinovirus, and human coronavirus.

Conclusions:

  • Post-COVID-19 pandemic, a significant increase in pediatric respiratory pathogen detection and coinfection rates was observed.
  • Resurgence of seasonal patterns for influenza and parainfluenza, an outbreak of Mycoplasma pneumoniae, and altered RSV seasonality occurred.
  • Increased susceptibility in neonates (0-28 days) and older children (>3 years) highlights the need for vigilance regarding respiratory disease trends.